1. Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages. Issue 1 (8th December 2016) Authors: Antsiferova, Maria; Piwko‐Czuchra, Aleksandra; Cangkrama, Michael; Wietecha, Mateusz; Sahin, Dilara; Birkner, Katharina; Amann, Valerie C; Levesque, Mitchell; Hohl, Daniel; Dummer, Reinhard; Werner, Sabine Journal: EMBO molecular medicine Issue: Volume 9:Issue 1(2017) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy. (November 2018) Authors: Krieg, Carsten; Nowicka, Malgorzata; Guglietta, Silvia; Schindler, Sabrina; Hartmann, Felix; Weber, Lukas; Dummer, Reinhard; Robinson, Mark; Levesque, Mitchell; Becher, Burkhard Journal: Nature medicine Issue: Volume 24:Number 11(2018) Page Start: 1773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients. Issue 2 (19th July 2021) Authors: Mitamura, Yasutaka; Schulz, Daniel; Oro, Saskia; Li, Nick; Kolm, Isabel; Lang, Claudia; Ziadlou, Reihane; Tan, Ge; Bodenmiller, Bernd; Steiger, Peter; Marzano, Angelo; de Prost, Nicolas; Caudin, Olivier; Levesque, Mitchell; Stoffel, Corinne; Schmid‐Grendelmeier, Peter; Maverakis, Emanual; Akdis, ... Journal: Allergy Issue: Volume 77:Issue 2(2022) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MAPK pathway in melanoma part II—secondary and adaptive resistance mechanisms to BRAF inhibition. (March 2017) Authors: Amaral, Teresa; Sinnberg, Tobias; Meier, Friedegund; Krepler, Clemens; Levesque, Mitchell; Niessner, Heike; Garbe, Claus Journal: European journal of cancer Issue: Volume 73(2017) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma. Issue 1 (December 2017) Authors: Restivo, Gaetana; Diener, Johanna; Cheng, Phil; Kiowski, Gregor; Bonalli, Mario; Biedermann, Thomas; Reichmann, Ernst; Levesque, Mitchell; Dummer, Reinhard; Sommer, Lukas Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The mitogen-activated protein kinase pathway in melanoma part I – Activation and primary resistance mechanisms to BRAF inhibition. (March 2017) Authors: Amaral, Teresa; Sinnberg, Tobias; Meier, Friedegund; Krepler, Clemens; Levesque, Mitchell; Niessner, Heike; Garbe, Claus Journal: European journal of cancer Issue: Volume 73(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma. Issue 3 (4th July 2020) Authors: Kaufmann, Corina; Kempf, Werner; Mangana, Joanna; Cheng, Phil; Emberger, Michael; Lang, Roland; Kaiser, Andreas K; Lattmann, Evelyn; Levesque, Mitchell; Dummer, Reinhard; Koelblinger, Peter Journal: Histopathology Issue: Volume 77:Issue 3(2020) Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗